Umesh Shaligram

Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial

Mehreen S. Datoo, Hamtandi Magloire Natama, Ousmane Traoré et al. · The Lancet · 2021 · 458 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial

Mehreen S. Datoo, Alassane Dicko, Halidou Tinto et al. · The Lancet · 2024 · 351 citations · Full text

Veterinary Medicine, Child Health, Pediatrics +17

Efficacy and immunogenicity of R21/Matrix-M vaccine against clinical malaria after 2 years' follow-up in children in Burkina Faso: a phase 1/2b randomised controlled trial

Mehreen S. Datoo, Hamtandi Magloire Natama, Duncan Bellamy et al. · The Lancet Infectious Diseases · 2022 · 288 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +12

Safety and immunogenicity of VPM1002 versus BCG in South African newborn babies: a randomised, phase 2 non-inferiority double-blind controlled trial

Mark F. Cotton, Shabir A. Madhi, Angelique Kany Kany Luabeya et al. · The Lancet Infectious Diseases · 2022 · 69 citations

Medicine, Immunology, Pediatrics +16

Challenge studies in Rhesus monkeys immunized with candidate hepatitis E vaccines: DNA, DNA-prime-protein-boost and DNA-protein encapsulated in liposomes

Vidya A. Arankalle, Kavita S. Lole, Tejaswini M. Deshmukh et al. · Vaccine · 2008 · 54 citations

Veterinary Medicine, Immunology, Infectious Diseases +16